The use of SGLT2 inhibitors primarily showed the effects on urinary glucose and sodium excretion, which results in osmotic diuresis and potential dehydration [184], and increased urinary uric acid excretion, which is also correlated with a risk factor of acute kidney injury through urate crystal-dependent and independent mechanisms [185]. This evidence concerns the gene SLC5A2 and acute kidney injury.